Research Article
Ultrasensitive and automated 1 pg/ml fluticasone propionate assay in human plasma using LC–MS/MS
Published Online:18 Feb 2013https://doi.org/10.4155/bio.12.338
Abstract
Background: To develop and validate an ultrasensitive bioanalytical assay for quantitation of fluticasone propionate in human plasma, aliquots of 0.6 ml of K3EDTA human plasma were treated with zinc sulfate solution and loaded onto a preconditioned SPE plate. The sample solutions were washed, eluted, dried and reconstituted. The extracted sample was injected onto a LC–MS/MS system and separated by a reverse-phase HPLC column with a 5 min gradient program, and detected by MS/MS for fluticasone propionate quantitation. Results: Linearity was from 1 to 200 pg/ml. The intra- and inter-day accuracy and precision of the assay met validation acceptance criteria. Various stabilities were established and interference drug assessment was evaluated. The assay has been used for clinical studies. Conclusion: This ultrasensitive method has been successfully validated using LC–MS/MS for determination of fluticasone propionate in human plasma at low pg/ml level.
Papers of special note have been highlighted as: ▪ of interest
References
- 1 Crim C, Pierre LN, Daley-Yates PT. A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate. Clin. Ther.23(9),1339–1354 (2001).
- 2 US FDA. Guidance for drug Evaluation and Research. Guidance for Industry: Bioanalytical Method Validation. May 2011.
- 3 Krishnaswami S, Mollmann H, Derendorf H et al. A sensitive LC–MS/MS method for the quantification of fluticasone propionate in human plasma. J. Pharm. Biomed. Anal.22,123–129 (2000).
- 4 Laugher L, Noctor TG, Barrow A et al. An improved method for the determination of fluticasone propionate in human plasma. J. Pharm. Biomed. Anal.21,749–758 (1999).
- 5 Mascher HJ, Zech K, Mascher DG. Sensitive simultaneous determination of cicesonide, ciclesonide-M1-metabolite and fluticasone propionate in human serum by HPLC–MS/MS with APPI. J. Chromtogr. B.869,84–92 (2008).
- 6 Callejas SL, Biddlecombe RA, Jones AE et al. Determination of the glucocorticoid fluticasone propionate in plasma by automated solid-phase extraction and liquid chromatography–tandem mass spectrometry. J. Chromtogr. B.718,243–250 (1998).
- 7 Li YN, Tattam BN, Brown KF et al. A sensitive method for the quantitation of fluticasone propionate in human plasma by high-performance liquid chromatography/atmosphereic pressure chemical ionization mass spectrometry. J. Pharm. Biomed. Anal.16,447–452 (1997).▪ Non-automated method for fluticasone propionate human plasma assay at mid-to-high pg/ml.
- 8 Byrro RMD, Cesar IC, Cardoso FF et al. A rapid and sensitive HPLC-APCI–MS/MS method determination of fluticasone in human plasma: application for a bioequivalency study in nasal spray formulations. J. Pharm. Biomed. Anal.61,38–43 (2012).▪ Non-automated method for fluticasone propionate human plasma assay at 2 pg/ml.
- 9 Carter SJ, Capka V. Investigation of interaction between salmeterol and fluticasone prpionate and its effect on quantitative accuracy of an LC–MS/MS assay in human plasma at low pg/ml concentrations. J. Chromatogr. B.876,163–169 (2008).▪ Non-automated method for fluticasone propionate human plasma assay at mid-to-high pg/ml.
- 10 Mather J, Graham K, Bhttacharya D et al. LC–MS/MS quantification of fluticasone propionate in human plasma at the fg/ml level. Presented at: Chemical & Pharmaceutical Structure Analysis 2011. Langhorne, PA, USA, 3–6 October 2011 (Poster abstract #07).
- 11 DiGiorgio AM, Linderholm KH, Naghmouchi S et al. Sensitive LC–MS/MS assay of fluticasone propionate in human EDTA plasma with semi-automated sample preparation. Presented at: 75th AAPS Meeting 2008. Atlanta, GA, USA, 16–20 November 2008.
- 12 Smith N, Jean N, Pelletier N et al. Ultra low pictograms determination of a glucocorticoid in human plasma. Presented at: The 59th ASMS Conference on Mass Spectrometry and Allied Topics. Denver, CO, USA, 5–9 June 2011 (Poster title #TP273).
- 13 Keller J, Mather J, Zheng N et al. LC–MS/MS quantification of fluticasone furoate in human plasma at the fg/ml level. Presented at: The 59th ASMS Conference on Mass Spectrometry and Allied Topics. Denver, CO, USA, 5–9 June 2011 (Poster #MP163).
- 14 Crompton GK. Fluticasone propionate bioavailability in asthma. Lancet356,1681–1682 (2000).
- 15 Jenkins KD, Shenoy EVB, Pateman AJ et al. Methodological surveys in biochemistry and analysis. In: Bioanalytical Approaches for Drugs, Including Anti-Asthmatic and Metabolites. Reid E, Wilson ID (Eds). Royal Society of Chemistry, 22,205–210 (1992).
- 16 Zhou D, Zhou G, Scotto C et al. A highly sensitive and specific LC–MS/MS method (3 pg/ml) for quantitation of fluticasone propionate in human plasma. Presented at: The 51st Conference of the American Society of Mass Spectrometry and Allied Topics. Montreal, Canada 3–7 June 2003.
- 17 Mather J, Rainville PD, Graham KS et al.Waters Application Note. A High Sensitivity UPLC–MS/MS Method for the Analysis of Fluticasone Propionate in Plasma. Waters Corporation, Milford, MA, USA (2009).
